Recent papers suggest protective ventilation (PV) as a primary ventilation strategy during one-lung ventilation (OLV) to reduce postoperative pulmonary morbidity. However, data regarding the advantage of the PV strategy in patients with normal preoperative pulmonary function are inconsistent, especially in the case of minimally invasive thoracic surgery. Therefore we compared conventional OLV (V T 10 ml/kg, FiO 2 1.0, zero PEEP) to protective OLV (V T 6 ml/kg, FiO 2 0.5, PEEP 5 cmH 2 O) in patients with normal preoperative pulmonary function tests undergoing video-assisted thoracic surgery. Oxygenation, respiratory mechanics, plasma interleukin-6 and malondialdehyde levels were measured at baseline, 15 and 60 minutes after OLV and 15 minutes after restoration of two-lung ventilation. P a O 2 and P a O 2 /FiO 2 were higher in conventional OLV than in protective OLV (P <0.001). Interleukin-6 and malondialdehyde increased over time in both groups (P <0.05); however, the magnitudes of increase were not different between the groups. Postoperatively there were no differences in the number of patients with P a O 2 /FiO 2 <300 mmHg or abnormalities on chest radiography. Protective ventilation did not provide advantages over conventional ventilation for video-assisted thoracic surgery in this group of patients with normal lung function.
A protective ventilation (PV) strategy consists of a small tidal volume (V T ) with positive end-expiratory pressure (PEEP), limited airway pressure and low FiO 2 . PV has been shown to reduce lung injury in patients with acute respiratory distress syndrome [1] [2] [3] [4] . Acute lung injury (ALI) is a serious morbidity after thoracic surgery and the intraoperative ventilator settings have been suggested as one of the factors triggering postoperative ALI 5 . During one-lung ventilation (OLV), hyperoxia, hyperperfusion and hyperinflation of the dependent lung, in addition to ischaemia-reperfusion injury and surgical trauma of the operated lung, can inflict exaggerated inflammatory and oxidative damage that subsequently leads to ALI 6, 7 . Therefore, a PV strategy has recently been suggested as a primary ventilator setting during OLV to reduce postoperative pulmonary morbidity 5, [8] [9] [10] .
However, data regarding use of the PV strategy in patients with normal preoperative pulmonary function tests (PFT) are inconsistent [11] [12] [13] [14] [15] [16] [17] , especially in the case of minimally invasive video-assisted thoracic surgery (VATS) 18 . A PV strategy might have disadvantages in the operating theatre where sudden respiratory incidents, such as double-lumen tube malposition and desaturation, are not rare. The PV strategy reduces the safety margin against hypoxia and limits the anaesthetist's available time for corrective measures. It is also important to maintain arterial oxygen tension during OLV, because of persistent blood flow to the collapsed lung and ventilation-perfusion mismatch in the dependent lung.
Analysis of the hazards and benefits between conventional ventilation and PV should be considered, especially for patients who do not have severely compromised lungs and are undergoing minimally invasive thoracic surgery where the chance of ALI due to mechanical ventilation is small.
In this prospective and controlled study, we examined whether intraoperative protective OLV could attenuate systemic inflammation and improve postoperative respiratory outcomes in patients with normal preoperative PFTs undergoing VATS lobectomy. The primary endpoint of this study was to evaluate systemic inflammatory and oxidative stress in conventional and PV strategies. The secondary endpoint was to compare oxygenation, respiratory parameters and postoperative respiratory outcomes between the two strategies.
MATERIALS AnD METHODS

Patient population and management
This study was approved by our institutional review board (IRB approval number: 2009-01-043-002) and was registered as an international clinical trial (registration number: ACTRn12610000477022). Written informed consent for enrolment in the study was obtained from each patient. From August 2009 to March 2010, patients with American Society of Anesthesiologists physical status I-II who were scheduled for an elective VATS lobectomy were enrolled in the study. The exclusion criteria included refusal to participate, significant pulmonary disease with abnormalities in spirometry (one second forced expiratory volume less than 80% of the predicted value and/or a ratio of one second forced expiratory volume over forced vital capacity of less than 0.7), chronic renal failure, altered liver function, preoperative corticosteroid treatment in the month before surgery, elevated temperature or leukocyte count, or any new pulmonary infiltration on chest radiography (CXR). As a result, a total of 62 patients were initially enrolled in the study. Patients were randomised into the conventional ventilation (CV) group or the PV group via a computer-generated randomisation technique (www.randomizer.org).
Prior to induction of anaesthesia, a thoracic epidural catheter was inserted via an intervertebral space between T4 and T7. A continuous infusion (ropivacaine 0.14% with hydromorphone 16 µg/ml) at 4 ml/hour was commenced at OLV 15; postoperatively this was continued as the background rate component of epidural patient-controlled analgesia with a bolus 1.5 ml and lockout 15 minutes, and was maintained for two to three days. Patients who refused or failed epidural analgesia received intravenous patient-controlled analgesia (fentanyl 15 µg/ml plus ketorolac 1.8 mg/ml with a bolus of 1 ml, lockout 15 minutes), and the background infusion rate of 1 ml/hour was commenced at OLV 15.
using standard monitoring, the trachea was intubated after administration of sodium thiopentone (5 mg/kg), rocuronium (0.8 mg/kg) and fentanyl (1 µg/kg). Anaesthesia was maintained with inhaled sevoflurane in a 1:1 mixture of oxygen and air. After induction of anaesthesia, all patients received a radial artery catheter for continuous arterial blood pressure measurements and arterial blood sam-pling. Surgeons, experienced in major lung resection, conducted each operation and were unaware of the study protocol. Standardised fluid replacement consisted of lactated Ringer's solution 10 ml/kg preoperatively, followed by 6 ml/kg/hour perioperatively. If mean arterial pressure was less than 70 mmHg for more than five minutes or if the hourly urine output was less than 0.3 ml/kg, an additional fluid challenge was performed with hydroxyethyl starch (Voluven ® , Fresenius Kabi, germany) 10 ml/kg. Two chest drains were placed before the end of the operation and removed when the amount of daily drainage decreased to below 100 ml/day and there was no apparent air leakage.
After surgery, all patients were extubated and admitted to the intensive care unit (ICu). After extubation, patients were observed while on supplemental oxygen for 30 minutes followed by observation in room air. Supplemental oxygen was resumed if the SpO 2 value was <95%. Patients were cared for by attending ICu physicians who were not involved in the protocol and who were blinded to the study groups.
Study protocol
After tracheal intubation with a left-sided doublelumen tube (Broncho-Cath ® 35F or 37F; Mallinckrodt Medical Ltd, Ireland) for right lung lobectomy and a right-sided tube for left lobectomy (inserted using fibreoptic bronchoscopy), mechanical ventilation was initiated and gas flow and airway pressure were monitored. During two-lung ventilation (TLV), all patients received the same ventilation protocol consisting of FiO 2 0.5, V T of 10 ml/kg predicted body weight, zero PEEP and volume-controlled ventilation with an inspiratory pause of 30% and I:E=1:2. During OLV, the CV group received the same ventilation protocol except that the FiO 2 was 1.0. The PV group received FiO 2 0.5, PEEP 5 cmH 2 O and pressurecontrolled ventilation, and pressure was adjusted to achieve a V T reading of 6 ml/kg body weight. Respiratory frequencies were adjusted to achieve a P a CO 2 between 35-45 mmHg throughout anaesthesia. The maximum allowable peak inspiratory pressure was set at 30 cmH 2 O; if this value was exceeded, volume-controlled ventilation was changed to pressure-controlled ventilation. If it was not possible to reduce peak inspiratory pressure with this method or if the patient was already on pressure-controlled ventilation, V T was reduced by 1 ml/kg. The minimum SpO 2 allowed during the operation was 95%. In cases of SpO 2 <95% in the PV group, FiO 2 was increased by 0.2 at three-minute intervals until FiO 2 reached 1.0. In both groups, if SpO 2 fell below 95% with FiO 2 at 1.0 continuous positive airway pressure on the operated lung or intermittent TLV was applied, these cases were excluded from the study. The anaesthetists were not blinded to the strategy used, but they were not involved in the arterial blood analysis or in collection of ventilation parameters or ICu data.
Respiratory parameters and arterial blood gases were analysed at baseline (in the lateral decubitus position before application of ventilation strategy), 15 minutes and 60 minutes after initiation of OLV (OLV 15 and OLV 60 respectively) and 15 minutes after the restoration of TLV (TLV 15). Arterial blood samples were collected in EDTA tubes for the measurement of serum interleukin-6 (IL-6) and malondialdehyde (MDA) at baseline, OLV 60 and TLV 15. Blood was centrifuged at 1500 g for ten minutes at 4°C. The supernatant was collected and stored at -70°C until measurements were performed. Plasma IL-6 concentrations were measured with a quantitative sandwich enzyme immunoassay technique using a commercial kit (Quantikine Immunoassay Kit, R&D Systems, Minnesota, uSA). Plasma MDA content was determined via the thiobarbituric acid reaction using a commercial kit (TBARS Assay Kit, Cayman Chemical Company, Miami, uSA). The lower detection limits for IL-6 and MDA were 0.7 pg/ml and 0.1 nmol/ml respectively. When cytokines were not detectable, the minimum detectable level was used in the calculations.
For respiratory outcomes arterial blood gas analysis was performed two hours after arrival in the ICu and at 3.00 am the next day. Chest X-rays were taken every morning for three days. A single radiologist who was blinded to the treatment group and the clinical condition of each subject evaluated each radiograph. The radiographs were divided into four quadrants (right upper, right lower, left upper and left lower) and each quadrant was scored based on the intensity of infiltrates as follows: 0=no infiltrate, 1=less than one-third of the quadrant opacified, 2=one-third to two-thirds of the quadrant opacified and 3=greater than two-thirds of the quadrant opacified. The sum of the quadrant scores was converted into a chest radiographic assessment score. ALI was diagnosed as sudden onset of respiratory distress, diffuse pulmonary infiltrates on the chest radiograph consistent with alveolar oedema, impaired oxygenation with a P a O 2 /FiO 2 ratio <300 mmHg and absence of hydrostatic pulmonary oedema due to cardiac insufficiency or fluid overload (determined on the basis of pulmonary arterial catheterisation, echocardiogram, laboratory data [creatine kinase-MB, troponin I], clinical evaluation or a combination of these) 19 .
Statistical analysis
The sample size for this study was determined using the IL-6 value at the restoration of TLV 15. Twentyfour patients per group were required to detect a 50% difference in mean IL-6 value between two groups with an estimated standard deviation (SD) of 60%, a power of 80% and a 5% risk of a type 1 error based on a previous study 9 .
Data were tested for normal distribution with the Lillifors test 20 . normally distributed data are presented as mean (SD), and skewed data as both median (interquartile range) and mean (SD). Student's t-test or rank sum test was used for continuous variables and Pearson's chi-square test or Fisher's exact test was applied for categorical variables. The intraoperative data (including airway pressure, tidal volume, respiratory rate, pH, FiO 2 , P a O 2 and P a CO 2 ) were compared between groups at the corresponding time points using Student's t-test with a Bonferroni correction for unequal variances. Within-group, repeated measure values of IL-6 and MDA were compared using one-way analysis with repeated measurements and significant results were analysed using Tukey's post hoc test. To supplement the overall repeated measures analysis, groups were also compared at each time point using the two sample t-tests or rank sum test for unequal variances with Bonferroni correction. P <0.05 was considered statistically significant. Statistical analysis was performed with the software program SAS 9.1.3 (SAS institute, Inc., Cary, nC, uSA).
RESuLTS
Of the 62 patients, ten were excluded from the study due to changes in the surgical plan or bleeding and two patients in the PV group required a rescue method of continuous positive airway pressure on the operated lung due to a drop in the SpO 2 below 95% with FiO 2 at 1.0. Therefore 25 patients in each group were entered into the final analysis ( Figure 1 ).
There were no major differences in demographic or operational data between the two groups (Tables  1 and 2) .
Intraoperative respiratory parameters including airway pressure, V T and P a O 2 measured at baseline were not different between the CV and PV groups, although the CV group showed a higher peak inspiratory pressure at OLV 60 than the PV group. The P a O 2 was lower in the PV group at both OLV 15 and OLV 60 compared to those in the CV group. These differences disappeared when TLV was Data are expressed as mean (SD) or number of patients (%). There were no differences between the groups. CV=conventional ventilation, PV=protective ventilation, surgeon=four surgeons were identified as one to four, OLV=one-lung ventilation, epidural=epidural patient-controlled analgesia, IV PCA=intravenous patient-controlled analgesia. restored (Figure 2 ). Baseline P a O 2 /FiO 2 values in both groups dropped at OLV 15 and became significantly different at OLV, although this difference disappeared postoperatively (Figure 3 ).
Six patients (24%) in the CV group showed peak inspiratory pressure >30 cmH 2 O, so the volumecontrolled ventilation mode was changed to a pressure-controlled mode to achieve a targeted V T according to our study protocol. Eight patients (32%) in the PV group could not attain SpO 2 >95% with our protocol; therefore, FiO 2 was increased in these patients.
IL-6 levels at baseline were not significantly different between the two groups. IL-6 values increased at OLV 60 in both groups and increased further at TLV 15 (all, P <0.05 compared with baseline values within the same group), although there were no significant differences in IL-6 level between the two groups at any time point (Table 3) . Blood MDA level also significantly increased at OLV 60 and TLV 15 compared with baseline in both groups, although there were no significant differences between the groups at any time point (Table 3) .
Regarding postoperative complications, there was no significant difference in the number of patients with postoperative P a O 2 /FiO 2 <300 mmHg between the two groups. The incidence of abnormal findings on CXR was 40% in the CV group and 32% in the PV group (P=0.768). Atelectasis, infiltration or chest radiographic assessment score on CXR were not significantly different between the two groups. There was no significant difference in newly developed postoperative arrhythmia or hospital length-of-stay between the two groups. neither group developed other postoperative hospital complications including renal, hepatic or other organ system dysfunction ( Table 4 ).
DISCuSSIOn
This study showed three main findings. First, the plasma levels of IL-6, recognised as one of the most important cytokines predictive of postoperative respiratory morbidity following mechanical ventilation 21, 22 , were not different between the groups. There is some controversy over the release of inflammatory cytokines in relation to high V T in normal lungs. Some experiments have reported only minimal cytokine response to lung overdistension in the absence of pre-existing injury or inflammation 13, 23 . To our knowledge, two previous studies have measured inflammatory cytokines in patients ventilated with the conventional or protective OLV method 9, 24 . The conventional OLV method resulted in a higher blood IL-6 response at the end of OLV compared to that with protective OLV in oesophagectomy patients 9 . However, Schilling et al 24 did not find a difference in the levels of IL-8, another major cytokine responsible for alveolar inflammation, in bronchoalveolar lavage fluid following conventional and protective OLV in patients who underwent various thoracotomy operations.
Our study showed that blood IL-6 concentration increased at OLV 60 and TLV 15 in both groups, but there was no significant difference between the groups. The highest value of IL-6 measured in our study was only 35.3 pg/ml (TLV 15 in the CV group), which can barely be considered clinically relevant when compared with the values in oesophagectomy (>100 pg/ml) 9 . In the case of oesophagectomy, 'multiple hits' due to the surgical procedure and mechanical ventilation might have provoked a much higher release of IL-6. Therefore, our study indicates that CV during OLV did not result in increased systemic inflammation compared to PV in patients with normal preoperative PFTs undergoing VATS. However, we had sufficient power to detect only a 50% or greater difference so cannot exclude the possibility of a smaller difference. Malondialdehyde is a product of lipid peroxidation and has been widely used as an indicator of oxidative stress. An increase in the concentration of reactive oxygen species reflects the interaction of endothelial factors and neutrophils or free radicals. The cyclic stretching of the lung during mechanical ventilation can cause a redox imbalance and an increase in MDA level. Rats ventilated with V T 35 ml/kg showed elevated oxidative stress levels in the lung 25 . Oxidative stress also increases after lung re-expansion, which is related to OLV duration 26 and oxygen 27 . In our study, the blood MDA level increased over time in both groups, but was not different between the groups at any time. This suggests that VATS employing a two to three-hour duration of OLV does not induce a substantial difference in redox imbalance between the two ventilation strategies.
Second, there were no significant differences in postoperative oxygenation, chest radiographs or respiratory outcome between the two ventilation strategies. A previous study 14 suggested that the end-inspiratory stretch might be relatively low, even with a V T 10 ml/kg predicted body weight, if the plateau pressure is low (e.g. <20 cmH 2 O). In the current study, the mean plateau pressure was near 20 cmH 2 O. In a previous animal study, V T 15 ml/kg with 3 cmH 2 O PEEP showed less histologic injury of the lung than V T 6 ml/kg with 3 cmH 2 O PEEP or V T 6 ml/kg with 10 cmH 2 O PEEP 13 . In children with acute hypoxaemic respiratory failure, a V T between 6 and 10 ml/kg was not associated with increased mortality and a higher V T within this range was associated with more ventilator-free days, especially for patients with less severe disease 16 . Most studies favouring lower V T ventilation-involved ill patients who were ventilated for several days in the ICu 28 . The current study shows that OLV with a V T of 10 ml/kg for two to three hours did not induce detrimental effects on postoperative outcome in patients without pre-existing lung disease.
Finally, OLV with the PV strategy showed a lower intraoperative P a O 2 and P a O 2 /FiO 2 ratio than OLV with the CV strategy. Eight patients (32%) in the PV group could not attain SpO 2 >95% and two patients required a rescue method of continuous positive airway pressure due to desaturation (SpO 2 <95%) with FiO 2 at 1.0 compared with none in the CV group. The advantage of the CV strategy, over the PV strategy with respect to oxygenation, could be explained by higher FiO 2 and improved alveolar recruitment due to a higher V T . PEEP applied to the ventilated lung in the PV group. This was supposed to raise the end-expiratory lung volume towards functional residual capacity preventing atelectasis in lower V T ventilation, although application of an adequate level of PEEP during thoracic surgery remains a challenging problem.
There are some limitations to this study. First, the study included only patients undergoing minimally invasive thoracoscopic surgery. This was because our primary endpoint was to evaluate the inflammatory cytokine response related to ventilation strategies associated with less surgical stimulation in order to minimise compounding factors on cytokine release during surgery. The results may not apply to open thoracic surgery. Second, we measured blood cytokine and MDA levels as predictive factors of postoperative pulmonary morbidity. Although locally produced inflammatory cytokine and MDA leak into the systemic circulation 29, 30 , direct measurement of these factors from bronchoalveolar lavage fluid or lung tissue might provide more specific information on lung inflammation. Third, blood MDA levels and secondary outcomes (including the incidence of P a O 2 /FiO 2 <300 mmHg and abnormal findings on CXR) were not adequately powered; therefore, these results are observations and not conclusive. Fourth, pain control methods could potentially influence our results. Epidural analgesia is known to reduce pulmonary complications 31 . Epidural analgesia was used in a similar portion of each group (approximately two-thirds of the patients) and intravenous patientcontrolled analgesia provides good analgesia in the case of VATS. Therefore, we consider the influence of analgesic methods in our results is small.
COnCLuSIOn
In conclusion, protective OLV did not appear to provide benefits in systemic inflammatory, oxidative stress or respiratory outcomes compared with conventional OLV in patients with normal preoperative PFTs undergoing VATS lobectomy.
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